A potential breakthrough in the treatment of anxiety with psychedelic inspired drugs. It works by increasing the neurons connectivity in the brain. This has the potential to address the root cause of anxiety, depression, substance abuse etc. Very promising!
The FDA’s decision to designate MM120 as a breakthrough therapy for GAD and the durability data from our Phase 2b study provide further validation of the important potential role this treatment can play in addressing the huge unmet need among individuals living with GAD.